Phathom Pharmaceuticals, Inc. PHAT Non Cash Settlement Of Employee Stock Purchase Plan Liability In Common Stock
Non Cash Settlement Of Employee Stock Purchase Plan Liability In Common Stock at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept phat:NonCashSettlementOfEmployeeStockPurchasePlanLiabilityInCommonStock.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s non cash settlement of employee stock purchase plan liability in common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s non cash settlement of employee stock purchase plan liability in common stock?
- Phathom Pharmaceuticals, Inc. (PHAT) reported non cash settlement of employee stock purchase plan liability in common stock of $1.54M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s non cash settlement of employee stock purchase plan liability in common stock changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s non cash settlement of employee stock purchase plan liability in common stock decreased by 17.0% year-over-year, from $1.85M to $1.54M.
- What does non cash settlement of employee stock purchase plan liability in common stock mean?
- This represents the value of employee stock purchase plan liabilities settled through the issuance of common stock rather than cash. It highlights the company's use of equity to fulfill compensation obligations, preserving cash for operational needs. This metric is a key component in evaluating the dilution impact of employee benefit programs.